Pharma Company Paying 300% Final Dividend, Ex-date Next Week, Q1 Profit Thrives To Rs. 2,061 Cr

Sun Pharmaceutical Industries (Sun Pharma), on May 31, 2022, announced a final dividend of 300%. The company's ex-dividend date will be next week, on August 22, 2022, and the record date will be on August 18, 2022. The shares of Sun Pharma are trading at a near 52-week high range, check details here.

Stock's performance on NSE - Sun Pharma

Sun Pharma's current market price on NSE stood at Rs. 912.55 falling by 0.92% till last traded. But, in the past 1 month, its share price surged by 7.16%, and in the past 6 months, its stock price has gained by 5.52%. In the past 1 year, its stock price has gained by 17.20%, amid a bearish market trend, and in the past 5 years, the stock's price has surged by 94.10%. It is a large-cap company with a market capitalization of Rs. 219,131 crore.

The 52-week high level of this stock is Rs. 967.05, and the 52-week low level of this stock is Rs. 733.70.

Company's financial performance

Sun Pharma recorded a thriving net profit of Rs. 2,061 crore in Q1FY23. The company's sales in the US have sharply gained in the quarter. Its total revenue from operations increased by 10.73% YoY to Rs. 10,761.76 crore in the same quarter.

A dividend is known as a reward, offered by a listed company. Paying a dividend is not mandatory, but a company can pay a dividend for attracting new investors, while benefiting the existing investors, after making significant profits in a recent quarter or fiscal.

Disclaimer

Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution. Greynium Information Technologies, the author, and the brokerage house are not liable for any losses caused as a result of decisions based on the article.